At close: January 3 at 5:29:45 PM GMT+1
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
-18,655.0000
-15,213.0000
-10,314.0000
-9,819.7660
-6,265.7280
Investing Cash Flow
-17,093.0000
-19,604.0000
-16,633.0000
-17,321.7380
-14,903.3870
Financing Cash Flow
30,517.0000
24,805.0000
30,150.0000
--
43,412.5480
End Cash Position
27,674.0000
22,026.0000
32,038.0000
28,835.5370
55,977.0410
Capital Expenditure
-17,093.0000
-19,604.0000
-16,633.0000
-17,321.7380
-14,903.3870
Issuance of Capital Stock
36,509.0000
26,284.0000
36,860.0000
--
53,362.8950
Free Cash Flow
-35,748.0000
-34,817.0000
-26,947.0000
-27,141.5040
-21,169.1150
12/31/2020 - 11/25/2015
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
ONCOZ.ST OncoZenge AB (publ)
3.5500
+0.28%
ELIC.ST Elicera Therapeutics AB (publ)
1.8900
+8.62%
ACTI.ST Active Biotech AB (publ)
0.1216
+3.93%
CANF.TA Can-Fite BioPharma Ltd.
2.0000
0.00%
STABL.ST Stayble Therapeutics AB (publ)
0.5500
-5.17%
ISOFOL.ST Isofol Medical AB (publ)
2.4900
+0.81%
ACE.ST Ascelia Pharma AB (publ)
2.9600
-3.43%
VICO.ST Vicore Pharma Holding AB (publ)
9.40
+1.40%
BIOA-B.ST BioArctic AB (publ)
212.00
+1.05%
PILA.ST Pila Pharma AB (publ)
4.5000
+12.78%